Mink Therapeutics Inc

Biotech Stocks Healthcare Stocks

$11.69

-0.22 (-1.85%)

As of Jun 30, 10:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +70.8% upside

Low Target $17.96

Average Target $19.97

High Target $26.10

Current Price $11.69

Current
$11.69

Target
$19.97

$17.96 $19.97 avg $26.10

Scenario Analysis

Bear Case

$17.96

53.6%

Low target

Base Case

$19.97

+70.8%

Avg target

Bull Case

$26.10

+123.3%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$76.00

-84.6% from high

52-Week Low

$6.80

+71.9% from low

Target vs 52W High

$19.97

-73.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%